Viewing Study NCT00164450


Ignite Creation Date: 2025-12-24 @ 5:19 PM
Ignite Modification Date: 2026-01-18 @ 6:37 PM
Study NCT ID: NCT00164450
Status: COMPLETED
Last Update Posted: 2008-08-25
First Post: 2005-09-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection
Sponsor: Centers for Disease Control and Prevention
Organization:

Organization Data

Organization:
Class: FED
Study ID: CDC-NCHSTP-4679
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: FED
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: William R. Mac Kenzie, MD, Medical Officer
Old Organization: Tuberculosis Trials Consortiu, DTBE, CDC

Collaborators

Collaborators

Name Class View
None FED View